[Federal Register Volume 87, Number 41 (Wednesday, March 2, 2022)]
[Notices]
[Page 11710]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04341]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CE22-009, Rigorous Evaluation of Community-Level 
Substance Use and Overdose Prevention Frameworks That Incorporate ACEs-
Related Prevention Strategies; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
CE22-009, Rigorous Evaluation of Community-Level Substance Use and 
Overdose Prevention Frameworks that Incorporate ACEs-Related Prevention 
Strategies; April 26-27, 2022, 8:30 a.m.-5:30 p.m. EDT, via Web 
Conference, in the original FRN. The meeting was published in the 
Federal Register on January 14, 2022, Volume 87, Number 10, page/s/
2439.
    The meeting is being amended to change the meeting date and should 
read as follows:
    CE22-009, Rigorous Evaluation of Community-Level Substance Use and 
Overdose Prevention Frameworks that Incorporate ACEs-Related Prevention 
Strategies: April 26, 2022.
    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific 
Review Official, National Center for Injury Prevention and Control, 
CDC, 4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341, 
Telephone (404) 639-6473, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-04341 Filed 3-1-22; 8:45 am]
BILLING CODE 4163-18-P